Traduire
Program here.…
Category Archives: Unclassified
Symposium’23 Program
3e matinée Carnot Star “9-12 Recherche-Industrie” dédiée à l’Imagerie, 17 Mars 2023, 8h30
FairEmbo en Afrique : “Ce médecin marseillais sauve des femmes avec des bouts de ficelle”
FairEmbo en Afrique : l’Embolisation-pour-tous franchit une nouvelle étape. Plus d’informations ici.…
Webinar: Discover Radiotheranostics in Nuclear Medicine (15 Sept. 2022)
Plus d’informations ici.…
Le projet EmboBio, développé au CERIMED, a reçu le prix de l’innovation AP-HM 2022
Plus d’informations sur le prix AP-HM de l’innovation 2022 ici.
Plus d’informations sur le projet Embobio dans cette vidéo.…
CERIMED OBTAINS DUAL ISO 9001:2015 AND NF X50-900:2016 CERTIFICATION FOR ITS PRE-CLINICAL RADIOLOGICAL AND NUCLEAR SERVICE AND INNOVATION ACTIVITIES
On June 5, 2022, the European Center for Research in Medical Imaging (CERIMED, UMS AMU CNRS 2012) obtained dual ISO 9001:2015 and NF-X50-900 certification for its pre-clinical research service activities, at the outcome of the audit carried out by Lloyd’s Register Quality Assurance (LRQA).
For Professor Benjamin GUILLET, Radiopharmacist and Director of CERIMED, “it is a satisfaction that crowns a long work of formalization of rigorous practices already implemented in a highly regulated environment: that of preclinical imaging in vivo radiological and nuclear, and the development of innovative health products in this field.…
Symposium’21 Program
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”
Program here.…
VECT-HORUS and CERIMED Announce Collaboration to Support the Development of VECT-HORUS’ Theragnostic Agents
VECT-HORUS, a biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, has announced the signing of a collaboration agreement with CERIMED (European Centre for Research in Medical Imaging) to support the preclinical development of VECT-HORUS’ theragnostic agents. More info here.…
FAIR-Embo hopes to spread safe, cheap embolization around the world
We are proud to anounce that Pr Vincent Vidal (Marseille, France), Head of the Experimental Interventional Radiology Laboratory hosted at CERIMED, and colleagues have demonstrated the in vivo feasibility of arterial embolization with permanent and absorbable suture fragments, leading them to propose what they have termed the “FAIR-Embo” concept to the wider interventional radiology (IR) community.
More information here .…